Cupid Limited — Annual Report FY2026
Quality Scores
AI Summary
Cupid Limited is a specialized manufacturer of male and female condoms, lubricants, and IVD kits, currently undergoing a significant transition under new promoter leadership (Aditya Kumar Halwasiya). The company exhibits high operating margins (23-33%) and a strong return profile with ROCE frequently exceeding 30%. While historically a B2B and tender-driven business, recent quarters show a pivot toward aggressive FMCG retail expansion and capacity building. The market capitalization has seen an explosive 849% growth in the last year, reflecting high expectations of a fundamental business…
Key Changes
Cupid has successfully evolved from a pure-play male condom manufacturer into a diversified reproductive health and FMCG player. The strategic introduction of female condoms (a higher-margin product) was a pivotal moment in the last decade, followed by an expansion into IVD kits and personal lubricants. The product portfolio now includes perfumes, deodorants, and almond hair hair oil, signaling a move into the broader personal care market to reduce cyclicality and tender dependence. The acquisition by the Halwasiya group represents a new chapter focused on scaling the FMCG presence and digital transformation. Geographic expansion into over 100 countries has de-risked the revenue base from single-country regulatory shifts. The company is actively moving up the value chain from basic…
Management Commentary
The management landscape has fundamentally changed with the entry of Aditya Kumar Halwasiya as the lead promoter. There is a clear shift in vision from being a steady, niche manufacturer to an aggressive FMCG player, evidenced by the increase in the number of shareholders from 26k to over 200k in less than three years. Transparency in reporting and frequent investor communications (concalls) are high, but the rapid scale-up carries execution risk. Promoter skin-in-the-game remains high at 46%, and recent open market purchases by the promoter (June 2026) signal confidence. However, the pivot from a tender-based model to a brand-building model requires a totally different management skillset.
Financial Highlights
Revenue has grown at a 5-year CAGR of 19%, but TTM figures show a massive 95% jump, indicating a structural shift in scale. Operating margins are robust but volatile, ranging from 12% in poor quarters to nearly 50% in peak performance periods, largely influenced by the product mix (Female Condoms carry higher margins). Profit growth has outpaced sales growth at a 30% 5-year CAGR, demonstrating operating leverage. The balance sheet has expanded rapidly, with total assets moving from 152 Cr in 2021 to a projected 553 Cr by 2026. The recent jump in equity capital from 13 Cr to 134 Cr indicates significant corporate action and potential dilution/restructuring under the new management.
Major Opportunities
- High ROCE of 33.5%
- Strong revenue growth of 95% TTM
- Promoter increasing stake through open market
Major Risks
- Extremely high P/E ratio of 222x
- Trading at 53x Price to Book Value
- Negative Free Cash Flow in recent years
Unlock the full report
Unlock complete company intelligence with 20+ analysis sections, visual insights, AI chat, rankings, and downloadable PDF reports.